Pomalidomide-PEG5-Alkyne

Background Introduction

Pomalidomide-PEG5-Alkyne is a specialized E3 ligase ligand-linker conjugate designed for use in the development of PROTACs (Proteolysis Targeting Chimeras). Built on the pomalidomide scaffold, which serves as a high-affinity ligand for the cereblon (CRBN) E3 ubiquitin ligase complex, this product incorporates a PEG5 (polyethylene glycol 5) linker terminating in an alkyne moiety for facile bioorthogonal conjugation. This versatile design offers valuable functionality for researchers seeking to create next-generation targeted protein degradation molecules.

Mechanism

Pomalidomide-PEG5-Alkyne operates by engaging the CRBN E3 ligase within the cell while providing a 'handle'—the terminal alkyne—for attachment to other molecular components via click chemistry (such as copper-catalyzed azide-alkyne cycloaddition). In PROTAC construction, this ligand-linker connects the E3 ligase recruiting module (pomalidomide portion) to a ligand that binds the protein of interest (POI). Once assembled, the bifunctional molecule brings the POI and CRBN E3 complex into close proximity, promoting ubiquitination and subsequent proteasomal degradation of the target protein.

Applications

Pomalidomide-PEG5-Alkyne is ideally suited for the synthesis of CRBN-recruiting PROTACs. Its alkyne group enables efficient click chemistry with azide-modified molecules, supporting modular assembly of custom PROTAC libraries. The PEG5 linker boosts water solubility and improves pharmacokinetics, making it especially valuable in structure-activity relationship (SAR) studies, targeted protein degradation research, and the design of novel chemical probes. The product is extensively used in the fields of chemical biology, drug discovery, and early preclinical therapeutic development.

The E3 Ligase Ligand-Linker Conjugate, Pomalidomide-PEG5-Alkyne, plays a crucial role in the design of PROTACs by facilitating targeted protein degradation. It offers enhanced selectivity and efficacy in degrading disease-related proteins, making it an invaluable tool for research applications. The following provides a detailed description of this molecule.

Linker: The PEG5 linker in this conjugate is characterized by its flexible, hydrophilic nature, contributing to the overall solubility and bioavailability of the molecule. Its length allows optimal spatial orientation between the ligand and the target protein, while its non-cleavable nature ensures stability during cellular processes.

Ligand: The ligand component, Pomalidomide, is a thalidomide derivative known for its high affinity binding to the cereblon E3 ubiquitin ligase. Its structural characteristics enable efficient recruitment of the ubiquitin-proteasome system, facilitating the degradation of target proteins.

Reactive Site: The alkyne moiety serves as the reactive site in this molecule, enabling it to couple with azide-functionalized target protein ligands through a copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction, commonly known as "click chemistry," which is highly efficient and specific.

Recommended Target Protein Ligand: A compatible warhead for this conjugate would be an azide-functionalized small molecule or peptide, which allows for precise conjugation via click chemistry. This approach offers the advantage of robust and stable linkage formation, ideal for experimental studies aimed at exploring protein interactions and degradation pathways in a controlled manner.